An Adequately Robust Early TNF-α Response Is a Hallmark of Survival Following Trauma/Hemorrhage

Background Trauma/hemorrhagic shock (T/HS) results in cytokine-mediated acute inflammation that is generally considered detrimental. Methodology/Principal Findings Paradoxically, plasma levels of the early inflammatory cytokine TNF-α (but not IL-6, IL-10, or NO2 -/NO3 -) were significantly elevated within 6 h post-admission in 19 human trauma survivors vs. 4 non-survivors. Moreover, plasma TNF-α was inversely correlated with Marshall Score, an index of organ dysfunction, both in the 23 patients taken together and in the survivor cohort. Accordingly, we hypothesized that if an early, robust pro-inflammatory response were to be a marker of an appropriate response to injury, then individuals exhibiting such a response would be predisposed to survive. We tested this hypothesis in swine subjected to various experimental paradigms of T/HS. Twenty-three anesthetized pigs were subjected to T/HS (12 HS-only and 11 HS + Thoracotomy; mean arterial pressure of 30 mmHg for 45–90 min) along with surgery-only controls. Plasma obtained at pre-surgery, baseline post-surgery, beginning of HS, and every 15 min thereafter until 75 min (in the HS only group) or 90 min (in the HS + Thoracotomy group) was assayed for TNF-α, IL-6, IL-10, and NO2 -/NO3 -. Mean post-surgery±HS TNF-α levels were significantly higher in the survivors vs. non-survivors, while non-survivors exhibited no measurable change in TNF-α levels over the same interval. Conclusions/Significance Contrary to the current dogma, survival in the setting of severe, acute T/HS appears to be associated with an immediate increase in serum TNF-α. It is currently unclear if this response was the cause of this protection, a marker of survival, or both. This abstract won a Young Investigator Travel Award at the SHOCK 2008 meeting in Cologne, Germany.

[1]  Chung-Han Yang,et al.  Serial cytokine levels in patients with severe sepsis , 2009, Inflammation Research.

[2]  Jiaquan Xu,et al.  Deaths: final data for 2005. , 2008, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[3]  Gary An,et al.  Translational Systems Biology of Inflammation , 2008, PLoS Comput. Biol..

[4]  A. Peitzman,et al.  Male gender is associated with excessive IL-6 expression following severe injury. , 2008, The Journal of trauma.

[5]  S. Orfanos,et al.  Plasma pro- and anti-inflammatory cytokine levels and outcome prediction in unselected critically ill patients. , 2008, Cytokine.

[6]  G. Kostopanagiotou,et al.  Effect of exogenous catecholamines on tumor necrosis factor alpha, interleukin-6, interleukin-10 and beta-endorphin levels following severe trauma. , 2008, Vascular pharmacology.

[7]  M. Bianchi,et al.  High‐mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity , 2007, Immunological reviews.

[8]  A. Peitzman,et al.  Assessment of the clinical course with inflammatory parameters. , 2007, Injury.

[9]  K. Tracey,et al.  Systemic inflammation and remote organ injury following trauma require HMGB1. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[10]  K. Ward,et al.  Androstenetriol immunomodulation improves survival in a severe trauma hemorrhage shock model. , 2007, The Journal of trauma.

[11]  M. Donnino,et al.  Identification and resuscitation of the trauma patient in shock. , 2007, Emergency medicine clinics of North America.

[12]  G. Timberlake,et al.  Molecular analysis of inflammatory markers in trauma patients at risk of postinjury complications. , 2007, The Journal of trauma.

[13]  B. Maier,et al.  EARLY VERSUS LATE ONSET OF MULTIPLE ORGAN FAILURE IS ASSOCIATED WITH DIFFERING PATTERNS OF PLASMA CYTOKINE BIOMARKER EXPRESSION AND OUTCOME AFTER SEVERE TRAUMA , 2007, Shock.

[14]  M. Bianchi DAMPs, PAMPs and alarmins: all we need to know about danger , 2007, Journal of leukocyte biology.

[15]  T. Billiar,et al.  EMERGING PARADIGM: TOLL-LIKE RECEPTOR 4-SENTINEL FOR THE DETECTION OF TISSUE DAMAGE , 2006, Shock.

[16]  Rolf Lefering,et al.  Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. , 2006, The Journal of trauma.

[17]  K. Inaba,et al.  The Immunomodulatory Effects of Hypertonic Saline Resuscitation in Patients Sustaining Traumatic Hemorrhagic Shock: A Randomized, Controlled, Double-Blinded Trial , 2006, Annals of surgery.

[18]  G. Clermont,et al.  THE ACUTE INFLAMMATORY RESPONSE IN DIVERSE SHOCK STATES , 2005, Shock.

[19]  Mehmet Toner,et al.  Application of genome-wide expression analysis to human health and disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Y. Youn,et al.  The role of mediators in the response to thermal injury , 2005, World Journal of Surgery.

[21]  Richard L. George,et al.  Insights into the role of interleukin-6 in the induction of hepatic injury after trauma-hemorrhagic shock. , 2004, Journal of applied physiology.

[22]  Timothy G Buchman,et al.  Nonlinear dynamics, complex systems, and the pathobiology of critical illness , 2004, Current opinion in critical care.

[23]  I. Chaudry,et al.  The role of interleukin-10 in the regulation of the systemic inflammatory response following trauma-hemorrhage. , 2004, Biochimica et biophysica acta.

[24]  C. Born,et al.  Cytokines in patients with polytrauma. , 2004, Clinical orthopaedics and related research.

[25]  E. Martin,et al.  Glycoprotein IIB/IIIA‐Inhibition and Microcirculatory Alterations During Experimental Endotoxemia—An Intravital Microscopic Study in the Rat , 2004, Microcirculation.

[26]  Seaver,et al.  Nitric oxide as a secretory product of mammalian cells , 2004 .

[27]  David T. Huang,et al.  Early goal-directed therapy. , 2004, Critical care medicine.

[28]  Carl Nathan,et al.  Points of control in inflammation , 2002, Nature.

[29]  J. Siddiqui,et al.  Six at Six: Interleukin-6 Measured 6 H After the Initiation of Sepsis Predicts Mortality Over 3 Days , 2002, Shock.

[30]  P. Molina Noradrenergic Inhibition of TNF Upregulation in Hemorrhagic Shock , 2001, Neuroimmunomodulation.

[31]  I. Chaudry,et al.  Resistance of macrophages to the suppressive effect of interleukin-10 following thermal injury. , 2001, American journal of physiology. Cell physiology.

[32]  M. Funayama,et al.  Correlation between serum IL-6 levels and death: usefulness in diagnosis of "traumatic shock"? , 2001, The Tohoku journal of experimental medicine.

[33]  Y. Vodovotz,et al.  68 – Biology of Nitric Oxide: Measurement, Modulation, and Models , 2001 .

[34]  C. Dinarello,et al.  Proinflammatory cytokines. , 2000, Chest.

[35]  Hans-Dieter Volk,et al.  Catecholamines trigger IL-10 release in acute systemic stress reaction by direct stimulation of its promoter/enhancer activity in monocytic cells , 2000, Journal of Neuroimmunology.

[36]  L. Moldawer,et al.  ANTICYTOKINE THERAPIES FOR ACUTE INFLAMMATION AND THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME: IL‐10 AND ISCHEMIA/REPERFUSION INJURY AS A NEW PARADIGM , 2000, Shock.

[37]  J. Kirkpatrick,et al.  The effects of interleukin-10 in hemorrhagic shock. , 2000, The Journal of surgical research.

[38]  L. Kinzl,et al.  Is interleukin 6 an early marker of injury severity following major trauma in humans? , 2000, Archives of surgery.

[39]  Y. Vodovotz,et al.  TGFß and IL-10: inhibitory cytokines regulating immunity and the response to infection , 2000 .

[40]  B. Henderson,et al.  Novel Cytokine Inhibitors , 2000, Progress in Inflammation Research.

[41]  P. Wang,et al.  Organ dysfunction following hemorrhage and sepsis: mechanisms and therapeutic approaches (Review). , 1999, International journal of molecular medicine.

[42]  B. Foëx Systemic responses to trauma. , 1999, British medical bulletin.

[43]  M. Wilson,et al.  SELECTIVE MICROVASCULAR ENDOTHELIAL CELL DYSFUNCTION IN THE SMALL INTESTINE FOLLOWING RESUSCITATED HEMORRHAGIC SHOCK , 1998, Shock.

[44]  L. Kinzl,et al.  EARLY POSTTRAUMATIC INCREASE IN PRODUCTION OF NITRIC OXIDE IN HUMANS , 1998, Shock.

[45]  P. Wang,et al.  Increased gut permeability after hemorrhage is associated with upregulation of local and systemic IL-6. , 1998, The Journal of surgical research.

[46]  I. Chaudry,et al.  L-arginine restores the depressed cardiac output and regional perfusion after trauma-hemorrhage. , 1998, Surgery.

[47]  I. Marzi,et al.  Mediators in polytrauma – pathophysiological significance and clinical relevance , 1998, Langenbeck's Archives of Surgery.

[48]  Khusru Asadullah,et al.  Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury , 1998, Nature Medicine.

[49]  L. Moldawer,et al.  Exogenous human recombinant interleukin-10 attenuates hindlimb ischemia-reperfusion injury. , 1997, The Journal of surgical research.

[50]  H. Mcdevitt,et al.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Cavaillon,et al.  Regulation by anti-inflammatory cytokines (IL-4, IL-10, IL-13, TGFβ)of interleukin-8 production by LPS- and/ or TNFα-activated human polymorphonuclear cells , 1996, Mediators of inflammation.

[52]  T G Buchman,et al.  Experimental human endotoxemia increases cardiac regularity: results from a prospective, randomized, crossover trial. , 1996, Critical care medicine.

[53]  M. Pasquale,et al.  Early inflammatory response correlates with the severity of injury. , 1996, Critical care medicine.

[54]  K. Waxman Shock: ischemia, reperfusion, and inflammation. , 1996, New horizons.

[55]  J. Dipiro,et al.  Interleukin-10 is associated with the development of sepsis in trauma patients. , 1996, The Journal of trauma.

[56]  T. van der Poll,et al.  Endogenous IL-10 protects mice from death during septic peritonitis. , 1995, Journal of immunology.

[57]  C. Sprung,et al.  Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. , 1995, Critical care medicine.

[58]  E. Abraham,et al.  Contribution of tumor necrosis factor-alpha to pulmonary cytokine expression and lung injury after hemorrhage and resuscitation. , 1995, Critical care medicine.

[59]  L. Moldawer,et al.  Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses , 1995, The Journal of experimental medicine.

[60]  I. Marzi,et al.  EFFECT OF ANTI-TUMOR NECROSIS FACTOR α ON LEUKOCYTE ADHESION IN THE LIVER AFTER HEMORRHAGIC SHOCK: AN INTRAVITAL MICROSCOPIC STUDY IN THE RAT , 1995, Shock.

[61]  I. Chaudry,et al.  Mechanism of enhanced susceptibility to sepsis following hemorrhage. Interleukin-10 suppression of T-cell response is mediated by eicosanoid-induced interleukin-4 release. , 1994, Archives of surgery.

[62]  P E Pepe,et al.  Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. , 1994, The New England journal of medicine.

[63]  M. Ceska,et al.  Plasma endotoxin and cytokine concentrations in patients with hemorrhagic shock , 1994, Critical care medicine.

[64]  D. Altavilla,et al.  Role of tumor necrosis factor-alpha in acute hypovolemic hemorrhagic shock in rats. , 1994, The American journal of physiology.

[65]  A L Goldberger,et al.  Physiological time-series analysis: what does regularity quantify? , 1994, The American journal of physiology.

[66]  J. Cavaillon Cytokines and macrophages. , 1994, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[67]  R. Sauerwein,et al.  Cytokine Patterns in Patients After Major Vascular Surgery, Hemorrhagic Shock, and Severe Blunt Trauma Relation with Subsequent Adult Respiratory Distress Syndrome and Multiple Organ Failure , 1993, Annals of surgery.

[68]  W A Buurman,et al.  Effect of antitumour necrosis factor treatment on circulating tumour necrosis factor levels and mortality after surgery in jaundiced mice , 1993, The British journal of surgery.

[69]  W. R. Lamb,et al.  Early cytokine response to multiple injury. , 1993, Injury.

[70]  Z. Ba,et al.  Endothelial cell dysfunction occurs after hemorrhage in nonheparinized but not in preheparinized models. , 1993, The Journal of surgical research.

[71]  E. DeMaria,et al.  Hemorrhagic shock in endotoxin-resistant mice: improved survival unrelated to deficient production of tumor necrosis factor. , 1992, The Journal of trauma.

[72]  C. Thiemermann,et al.  Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[73]  Y. Vodovotz,et al.  Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. , 1992, The Journal of biological chemistry.

[74]  P Franchimont,et al.  Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. , 1992, Annals of surgery.

[75]  Y. Vodovotz,et al.  Macrophage deactivation by interleukin 10 , 1991, The Journal of experimental medicine.

[76]  A. Peitzman,et al.  Nitrogen oxide levels in patients after trauma and during sepsis. , 1991, Annals of surgery.

[77]  M. Sporn,et al.  Cytokines in context , 1991, The Journal of cell biology.

[78]  Z. Ba,et al.  Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage. , 1991, The American journal of physiology.

[79]  I. Chaudry,et al.  Hemorrhage and resuscitation: immunological aspects. , 1990, The American journal of physiology.

[80]  M. Lamy,et al.  Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. , 1989, Critical care medicine.

[81]  D. Green,et al.  Trauma and the immune response. , 1988, Immunology today.